Snowball logo
logo
CAI

Caris Life Sciences, Inc. Common Stock

CAI β€’ NASDAQ
$22.18-$0.08Β  (0.36%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202022202320242025TTM
Revenue
Total revenue
294258.5306.1412.3812989.6
COGS
109.9178.5216.8233.5272.9300.2
Gross Profit
184.280.0289.31178.8539.2689.4
Operating Expenses & Income
Operating Income
139.1(315.8)(319.6)(257.1)45.11153.3
Total Operating Expenses
45.07395.8408.9435.9494.1536.1
R&D Expenses
-101.3116.9113.945.3191.2
Selling General & Admin Expenses
27.31156.2152173.6225234.7
Earnings from Continuing Operations
Interest Expense
(61.56)(26.68)(31.61)(50.02)(56.85)(46.9)
Interest Income
-0.94711.267.12216.521.21
Income Tax Expense
1.8---469.9(0.111)
Net Income
Net Income
27.73(320.8)(341.4)(281.9)(538)105.1
Supplemental
EBIT
143.8(294.1)(309.8)(231.9)(11.23)-
EBITDA
254.5(245.9)(260.8)(183)11.38166.2
In millions of USD, except % and values per 1 share